<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Patent on VitaminDWiki</title><link>/categories/patent.html</link><description>Recent content in Patent on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 07 Oct 2023 00:00:00 +0000</lastBuildDate><atom:link href="/categories/patent/index.xml" rel="self" type="application/rss+xml"/><item><title>Patent for fighting COVID - Vitamin D is one of the ingredients</title><link>/posts/patent-for-fighting-covid-vitamin-d-is-one-of-the-ingredients.html</link><pubDate>Sat, 07 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/patent-for-fighting-covid-vitamin-d-is-one-of-the-ingredients.html</guid><description>&lt;h4 id="methods-of-treating-covid-19-infection---us11166971b2httpspatentsgooglecompatentus11166971b2eninventorsabinehazanoqsabinehazan">Methods of &lt;a href="https://patents.google.com/patent/US11166971B2/en?inventor=sabine+hazan&amp;amp;oq=sabine+hazan">treating COVID-19 infection - US11166971B2&lt;/a>&lt;/h4>
&lt;p>&amp;ldquo;antimicrobials comprise: chloroquine or hydroxychloroquine; azithromycin; vitamin C; vitamin D; and zinc; &amp;quot;&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;Optionally, the method of treatment comprises administering hydroxychloroquine in daily dosage range of 20 mg to 2,000 mg; administering azithromycin in a daily dosage range of 250 mg to 500 mg; administering vitamin C in a daily dosage range of 250 mg to 10,000 mg; administering vitamin D in a daily dosage range of 1,000 mg to 100,000 mg; and administering zinc in a daily dosage range of 5 mg to 100 mg.&amp;rdquo;&lt;/p></description></item><item><title>COVID treatment patent applied for - using Rutin, Vitamin D, Vitamin C, Magnesium, etc.</title><link>/posts/covid-treatment-patent-applied-for-using-rutin-vitamin-d-vitamin-c-magnesium-etc.html</link><pubDate>Sat, 30 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/covid-treatment-patent-applied-for-using-rutin-vitamin-d-vitamin-c-magnesium-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#promising-therapeutic-approach-for-sars-cov-2-infection-by-using-a-rutin-based-combination-therapy">Promising therapeutic approach for SARS-CoV-2 infection by using a rutin-based combination therapy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#note-rutin-is-very-similar-chemically-to-quercetin-which-increases-vitamin-d-getting-to-cells">Note: RUTIN is very similar chemically to Quercetin which increases Vitamin D getting to cells&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="promising-therapeutic-approach-for-sars-cov-2-infection-by-using-a-rutin-based-combination-therapy">Promising therapeutic approach for SARS-CoV-2 infection by using a rutin-based combination therapy&lt;/h4>
&lt;p>ChemMedChem. 2022 Apr 30. &lt;a href="https://doi.org/10.1002/cmdc.202200157">doi: 10.1002/cmdc.202200157&lt;/a> behind paywall&lt;/p>
&lt;p>Monika Mazik 1&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/rutin-ref-6.jpg" alt="image" width="700">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/rutin-reference-6.jpg" alt="image" width="700">
&lt;p>The development of new therapeutic approaches for SARS-CoV-2 infection is of particular current importance. The combination therapy proposed here is based on already proven, safe compounds. The natural compound rutin, one of the six therapy components, has the potential to inhibit both viral and host cell targets. In addition, this therapy involves the use of acetylsalicylic acid, vitamin C and vitamin D 3 , which should be administered together with calcium and magnesium. The importance of each component is briefly described in this article. Due to multiple anti-infective properties of rutin, it provides a basis for combating SARS-CoV-2 infection as well as various viral and bacterial co-infections observed in patients. There are strong indications for a good effect of this simple combination therapy, especially in the early stages of infection. It has the potential to be of interest both prophylactically and therapeutically, and offers the possibility of protection against severe disease progression.&lt;/p></description></item><item><title>Semi-activated Vitamin D given weekly (used by Spanish COVID-19 trial) – US patent application</title><link>/posts/semi-activated-vitamin-d-given-weekly-used-by-spanish-covid-19-trial-us-patent-application.html</link><pubDate>Wed, 23 Sep 2020 00:00:00 +0000</pubDate><guid>/posts/semi-activated-vitamin-d-given-weekly-used-by-spanish-covid-19-trial-us-patent-application.html</guid><description>&lt;h4 id="once-a-week-administration-of-25-hydroxy-vitamin-d3-to-sustain-elevated-steady-state-pharmacokinetic-blood-concentration">Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration&lt;/h4>
&lt;p>United States Patent Application 20200281947 Kind Code:A1&lt;/p>
&lt;p>Inventors: Deluca, Hector F. (Deerfield, WI, US). Plum, Lori A. (Arena, WI, US), Clagett-dame, Margaret (Deerfield, WI, US)&lt;/p>
&lt;p>An oral dosage form comprising a single dose of 25-hydroxy-vitamin D3 sufficient to elevate the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml for at least 7 days and a pharmaceutically suitable oral carrier system, wherein subsequent single doses at least every 7 days are sufficient to sustain the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml at steady-state pharmacokinetics is disclosed. A method of elevating and sustaining the blood level concentration of 25-hydroxy-vitamin D3 in a human in need thereof comprising&lt;/p></description></item><item><title>Vitamin D, glutathione, and heat shock protein to treat concussions, etc. – US Patent</title><link>/posts/vitamin-d-glutathione-and-heat-shock-protein-to-treat-concussions-etc-us-patent.html</link><pubDate>Tue, 24 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-glutathione-and-heat-shock-protein-to-treat-concussions-etc-us-patent.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-leslie-matthews-in-vitamindwiki">Dr. Leslie Matthews in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dr-matthews-conference-presentation--jan-2020">Dr. Matthews Conference presentation- Jan 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#us-patent-office-10500217">US Patent Office 10,500,217&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#newspaper-coverage">Newspaper coverage&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#7-minute-video-interview-with-transcript---dec-23-2019">7 minute Video Interview with transcript - Dec 23, 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#heat-shock-proteins">Heat Shock Proteins&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#glutathione">Glutathione&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#glutathione-and-covid-19">Glutathione and COVID-19&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="dr-leslie-matthews-in-vitamindwiki">Dr. Leslie Matthews in VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-trauma-and-blacks-dr-matthews-interview-with-transcript">Vitamin D, trauma, and blacks - Dr. Matthews interview with transcript - Jan 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/un-invited-dr-matthews-to-speak-about-vitamin-d-in-both-sept-and">UN invited Dr. Matthews to speak about Vitamin D in both Sept and Oct 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/fda-decided-to-double-vitamin-d-in-milk-after-talking-4-times-with-by-dr-matthews">FDA decided to double vitamin D in milk after talking 4 times with by Dr. Matthews – July 2016&lt;/a>&lt;/p></description></item><item><title>Chemotherapy hair loss – prevented or treated by Vitamin D, US patent application</title><link>/posts/chemotherapy-hair-loss-prevented-or-treated-by-vitamin-d-us-patent-application.html</link><pubDate>Sun, 24 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/chemotherapy-hair-loss-prevented-or-treated-by-vitamin-d-us-patent-application.html</guid><description>&lt;h4 id="preventing-or-mitigating-chemotherapy-induced-alopecia-using-vitamin-d">PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D&lt;/h4>
&lt;p>&lt;strong>United States Patent Application 20190343847&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/us20190343847a1.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Topical to scalp: 105 μg to 180 μg ( 4,000 IU – 7,200 IU)&lt;/strong>&lt;/p></description></item><item><title>Vitamin D from UV LEDs – US patent application</title><link>/posts/vitamin-d-from-uv-leds-us-patent-application.html</link><pubDate>Tue, 15 Oct 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-from-uv-leds-us-patent-application.html</guid><description>&lt;h4 id="20190308032httpwwwfreepatentsonlinecomy20190308032html">&lt;a href="http://www.freepatentsonline.com/y2019/0308032.html">20190308032&lt;/a>&lt;/h4>
&lt;p>&lt;strong>Claim 1&lt;/strong> An indoor lighting panel for mounting on a wall or to a ceiling, wherein the indoor lighting panel comprises: a housing; an arrangement of UV-B LEDs in the housing; and a fabric output screen which provides a UV-B exit surface, wherein the fabric output screen is at least partially transparent to UV-B light, wherein the fabric output screen has a linear mass density of between 40 and 200 denier, wherein the fabric output screen is at least partially opaque to visible light, and wherein the fabric of the fabric output screen exhibits no fluorescence or phosphorescence upon absorption of UV-B light.&lt;/p></description></item><item><title>Statin side-effects are reduced by Vitamin D – US patent Application</title><link>/posts/statin-side-effects-are-reduced-by-vitamin-d-us-patent-application.html</link><pubDate>Sun, 21 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/statin-side-effects-are-reduced-by-vitamin-d-us-patent-application.html</guid><description>&lt;h4 id="statin--vitamin-d-combination-drug-and-method-of-usehttpappftusptogovnetacginph-parsersect1pto2sect2hitoffp1u2fnetahtml2fpto2fsearch-boolhtmlr5fgl50co1anddpg01s122vitamind22ttlosttl22vitamind22rsttl22vitamind2220-20190111064">&lt;a href="http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;amp;Sect2=HITOFF&amp;amp;p=1&amp;amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;amp;r=5&amp;amp;f=G&amp;amp;l=50&amp;amp;co1=AND&amp;amp;d=PG01&amp;amp;s1=%22vitamin+d%22.TTL.&amp;amp;OS=TTL/%22vitamin+d%22&amp;amp;RS=TTL/%22vitamin+d%22%20">STATIN + VITAMIN D COMBINATION DRUG AND METHOD OF USE&lt;/a> 20190111064&lt;/h4>
&lt;p>&lt;strong>IF this application becomes a patent then Stain producers would have to pay a royality if they wanted to include Vitamin D in the same pill&lt;/strong>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>Patents&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/who-said-vitamin-d-could-not-be-patented">Who said vitamin D could not be patented&lt;/a>&lt;/p>
&lt;ul>
&lt;li>A patent is a good indication that Vitamin D can treat/prevent a health problem&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/some-vitamin-d-patents-in-2018">Some Vitamin D patents in 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>PCOS, Breast and many other cancers, Obesity, Fall prevention, Stroke and other Cardiovascular, Immune system, wounds and reduce scars, Kidney disease, Diabetes, improve fertility, decrease pregnancy problems, SAD, multiple sclerosis (2),chemoprevention of cancer, accelerate fracture healing, metabolic syndrome, periodontitis, gingivitis, endometreosis, hair loss due to Chemotherapy, asthma, allergy, PMS in girls, ADHD&lt;/p></description></item><item><title>Vitamin D Sulfate (found in breast milk) - several studies</title><link>/posts/vitamin-d-sulfate-found-in-breast-milk-several-studies.html</link><pubDate>Sun, 21 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-sulfate-found-in-breast-milk-several-studies.html</guid><description>&lt;p>&lt;strong>Summary as of March 2023 - Vitamin D3 sulfate does exist.&lt;br>
It is processed by many of the same genes at Vitamin D3.&lt;br>
The genes are not as efficient at processing the sulfate version.&lt;br>
Very little data exists at this time to indicate that the sulfate version is important.&lt;br>
It has been discussed for decades,&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#patent-application-2018">Patent application 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#synthesis-and-biological-activity-of-vitamin-d3-sulfate">Synthesis and biological activity of vitamin D3-sulfate&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sunlight-and-vitamin-d-theyre-not-the-same-thing---seneff-march-2021">Sunlight and Vitamin D: They&amp;rsquo;re Not the Same Thing! - Seneff (March 2021?)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-sulfate---a-lesser-form-might-be-important-for-cvd---masterjohn-feb-2023">Vitamin D SULFATE - a lesser form, might be important for CVD - Masterjohn Feb 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4---biochemistry-of-human-milk-behind-paywall---2022">4 - Biochemistry of Human Milk (behind paywall) - 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3-sulfate-and-vitamin-d-genes--march-2023">Vitamin D3 sulfate and Vitamin D genes – March 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="patent-application-2018">Patent application 2018&lt;/h4>
&lt;p>&lt;strong>CHOLECALCIFEROL SULFATE SALTS AND THEIR USE FOR THE TREATMENT OF VITAMIN D DEFICIENCY&lt;/strong>&lt;/p></description></item><item><title>Some Vitamin D patents in 2018</title><link>/posts/some-vitamin-d-patents-in-2018.html</link><pubDate>Tue, 02 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/some-vitamin-d-patents-in-2018.html</guid><description/></item><item><title>Improve Cognitive Health and Memory with Vitamin D and Omega-3 – World Patent</title><link>/posts/improve-cognitive-health-and-memory-with-vitamin-d-and-omega-3-world-patent.html</link><pubDate>Thu, 28 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/improve-cognitive-health-and-memory-with-vitamin-d-and-omega-3-world-patent.html</guid><description>&lt;h4 id="40-20180085382-compositions-and-methods-for-cognitive-health-and-memoryhttpspatentscopewipointsearchendetailjsfdocidus214320688recnum40officequerystringfp3a2822vitamind2229prevfiltersortoptionpubdatedescmaxrec898120">&lt;a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=US214320688&amp;amp;recNum=40&amp;amp;office=&amp;amp;queryString=FP%3A%28%22vitamin+d%22%29&amp;amp;prevFilter=&amp;amp;sortOption=Pub+Date+Desc&amp;amp;maxRec=8981%20">40. 20180085382 COMPOSITIONS AND METHODS FOR COGNITIVE HEALTH AND MEMORY&lt;/a>&lt;/h4>
&lt;p>15707966	Script Essentials, LLC	Suzy Cohen&lt;/p>
&lt;p>The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating heart disease and heart-related disorders, among other symptoms. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of about &lt;strong>1,000 to 5,000 IU of vitamin D&lt;/strong> , preferably cholecalciferol, about 250 to 1,250 mg of fish oil concentrate, about &lt;strong>200 to 1,200 mg of omega-3 fatty acids&lt;/strong> , about 200 to 700 mg of DHA, about 20 to 125 mg of EPA, and about 10 to 150 mg of other fatty acids. The composition can further comprise a palliative agent, and can be provided in the form of a softgel, powder, liquid or tablet.&lt;/p></description></item><item><title>Patent to maintain executive function (cognition) with Vitamin D</title><link>/posts/patent-to-maintain-executive-function-cognition-with-vitamin-d.html</link><pubDate>Wed, 27 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/patent-to-maintain-executive-function-cognition-with-vitamin-d.html</guid><description>&lt;p>&lt;strong>&lt;a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;amp;Sect2=HITOFF&amp;amp;p=1&amp;amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;amp;r=43&amp;amp;f=G&amp;amp;l=50&amp;amp;co1=AND&amp;amp;d=PTXT&amp;amp;s1=%22vitamin+d%22.ABTX.&amp;amp;OS=ABST/%22vitamin+d%22&amp;amp;RS=ABST/%22vitamin+d%22">Use of 25-hydroxyvitamin D3 to enhance executive functions&lt;/a>&lt;/strong> 	9,707,242&lt;/p>
&lt;p>&lt;strong>Note: This DSM patent is for ORAL vitamin D, not inhaled, injected, topical, etc.&lt;/strong>&lt;/p></description></item><item><title>Patent to treat secondary hyperparathyroidism with 30 ng Vitamin D</title><link>/posts/patent-to-treat-secondary-hyperparathyroidism-with-30-ng-vitamin-d.html</link><pubDate>Wed, 27 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/patent-to-treat-secondary-hyperparathyroidism-with-30-ng-vitamin-d.html</guid><description>&lt;p>&lt;strong>&lt;a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;amp;Sect2=HITOFF&amp;amp;p=1&amp;amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;amp;r=10&amp;amp;f=G&amp;amp;l=50&amp;amp;co1=AND&amp;amp;d=PTXT&amp;amp;s1=%22vitamin+d%22.ABTX.&amp;amp;OS=ABST/%22vitamin+d%22&amp;amp;RS=ABST/%22vitamin+d%22">Method of treating and preventing secondary hyperparathyroidism&lt;/a>&lt;/strong>&lt;/p>
&lt;p>9,913,852 OPKO, &amp;gt; 30 ng/mL&lt;/p>
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/who-said-vitamin-d-could-not-be-patented">Who said vitamin D could not be patented&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/modified-release-active-vitamin-d-calcifediol-for-those-with-poor-kidney-function-usd-10000-per-year">Modified release active Vitamin D (calcifediol ) for those with poor Kidney function (USD 10,000 per year) – April 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Vitamin D patented to treat ADHD</title><link>/posts/vitamin-d-patented-to-treat-adhd.html</link><pubDate>Wed, 27 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patented-to-treat-adhd.html</guid><description>&lt;p>&lt;strong>&lt;a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;amp;Sect2=HITOFF&amp;amp;p=1&amp;amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;amp;r=1&amp;amp;f=G&amp;amp;l=50&amp;amp;co1=AND&amp;amp;d=PTXT&amp;amp;s1=%22vitamin+d%22.ABTX.&amp;amp;OS=ABST/%22vitamin+d%22&amp;amp;RS=ABST/%22vitamin+d%22%20">Dietary supplements for treating ADHD and related disorders&lt;/a>&lt;/strong> 9,999,644&lt;/p>
&lt;p>Provided herein are compositions, methods of use thereof and kits comprising same for prophylaxis, alleviating or treating a subject with, or experiencing symptoms associated with, attention deficit disorder/attention deficit hyperactivity disorder (ADD/ADHD) and related disorders. Specifically, the compositions comprise a magnesium mineral, vitamin D and at least one botanical component, in amounts such that the supplement is effective for preventing, alleviating and/or treating a child, teen or adult subject with ADD/ADHD and related disorders or one or more symptoms associated with ADD/ADHD and related disorders.&lt;/p></description></item><item><title>Vitamin D fortification patents have earned Univ. of Wisconsin 300 million dollars– 2016</title><link>/posts/vitamin-d-fortification-patents-have-earned-univ-of-wisconsin-300-million-dollars-2016.html</link><pubDate>Thu, 26 May 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-fortification-patents-have-earned-univ-of-wisconsin-300-million-dollars-2016.html</guid><description/></item><item><title>Vitamin D receptor substitutes are being patented</title><link>/posts/vitamin-d-receptor-substitutes-are-being-patented.html</link><pubDate>Fri, 25 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-substitutes-are-being-patented.html</guid><description>&lt;h3 id="therapeutic-application-of-vitamin-d-receptor-ligands-an-updated-patent-review">Therapeutic application of vitamin D receptor ligands: an updated patent review.&lt;/h3>
&lt;p>Expert Opin Ther Pat. 2015 Sep 24:1-11. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Takada I1, Makishima M1.&lt;/p>
&lt;p>1a Nihon University School of Medicine, Division of Biochemistry, Department of Biomedical Sciences , 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan +81 3 39 72 81 99 ; +81 3 39 72 81 99 ; &lt;a href="mailto:makishima.makoto@nihon-u.ac.jp">makishima.makoto@nihon-u.ac.jp&lt;/a>.&lt;/p>
&lt;p>INTRODUCTION:&lt;/p>
&lt;p>The vitamin D receptor (VDR) is a promising drug target in the treatment of cancer, autoimmune disease, inflammation, infection and cardiovascular disease, as well as bone and mineral disorders. Although many VDR ligands have been developed and shown to activate VDR in vitro and in vivo, including vitamin D derivatives and non-secosteroidal compounds, a principal adverse effect of hypercalcemia has limited their clinical application.&lt;/p></description></item><item><title>Vitamin D patent application – note the medical claims</title><link>/posts/vitamin-d-patent-application-note-the-medical-claims.html</link><pubDate>Tue, 09 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patent-application-note-the-medical-claims.html</guid><description>&lt;h4 id="methods-for-controlled-release-oral-dosage-of-a-vitamin-d-compoundhttpwwwfreepatentsonlinecomy20140357603html">&lt;a href="http://www.freepatentsonline.com/y2014/0357603.html">Methods for Controlled Release Oral Dosage of a Vitamin D Compound&lt;/a>&lt;/h4>
&lt;p>&lt;strong>United States Patent Application 20140357603&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/patent-including-images.pdf">Download the Patent PDF with text and images from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;p>A few claims and comments by VitaminDWiki follow&lt;/p>
&lt;p>&lt;strong>Claim 34.&lt;/strong>&lt;/p>
&lt;p>The method of claim 21, wherein the patient has a disease selected from the group consisting of&lt;/p>
&lt;ul>
&lt;li>&lt;strong>cancer&lt;/strong> , including but not limited to&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>breast, lung, skin, melanoma, colon, colorectal, rectal, prostate and bone cancer; an&lt;/p></description></item><item><title>Tuberculosis is controlled by Interleukin-32 when it has enough Vitamin D – patent applied for</title><link>/posts/tuberculosis-is-controlled-by-interleukin-32-when-it-has-enough-vitamin-d-patent-applied-for.html</link><pubDate>Fri, 22 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-is-controlled-by-interleukin-32-when-it-has-enough-vitamin-d-patent-applied-for.html</guid><description>&lt;h3 id="new-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosishttpwwwvitamindcouncilorgvitamin-d-newsnew-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosis-vitamin-d-council-describes-the-study">&lt;a href="http://www.vitamindcouncil.org/vitamin-d-news/new-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosis/#">New interaction discovered between vitamin D and certain protein in tuberculosis&lt;/a> Vitamin D Council describes the study&lt;/h3>
&lt;h3 id="study-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patientshttpnewsroomuclaedureleasesstudy-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patients-ucla-newsroom">&lt;a href="http://newsroom.ucla.edu/releases/study-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patients">Study identifies protein that helps prevent active tuberculosis in infected patients&lt;/a> UCLA Newsroom&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>“When vitamin D levels were low, IL-32 was not able to kill the bacteria,”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>. . applied for a patent application for further development of IL-32 as a potential diagnostic marker to see which patients with latent TB are at risk for activation of the disease, as well as for use as a possible therapeutic to treat tuberculosis by stimulating antimicrobial activity.&lt;/p></description></item><item><title>Alzheimer risk reduced by combination of memantine and vitamin D (patented)</title><link>/posts/alzheimer-risk-reduced-by-combination-of-memantine-and-vitamin-d-patented.html</link><pubDate>Tue, 06 May 2014 00:00:00 +0000</pubDate><guid>/posts/alzheimer-risk-reduced-by-combination-of-memantine-and-vitamin-d-patented.html</guid><description>&lt;h4 id="vitamin-d-supplements-a-novel-therapeutic-approach-for-alzheimer-patients">Vitamin D supplements: a novel therapeutic approach for Alzheimer patients&lt;/h4>
&lt;p>&lt;a href="http://www.frontiersin.org/Journal/FullText.aspx?s=322&amp;amp;%20name=experimental%20pharmacology%20and%20drug%20discovery&amp;amp;%20ART%20DOI=10.3389/fphar.2014.00006%20">Frontiers in Pharmacology, 1663-9812&lt;/a> 09 Dec 2013, 08 Jan 2014, 08 Jan 2014&lt;/p>
&lt;p>Cedric Annweiler, Spyridon N Karras, Panagiotis Anagnostis and Olivier Beauchet&lt;/p>
&lt;p>Opinion Article&lt;/p>
&lt;p>&lt;a href="https://www.frontiersin.org">www.frontiersin.org&lt;/a>&lt;/p>
&lt;p>Vitamin D supplements: a novel therapeutic approach for Alzheimer patients; Running title: Vitamin D supplements in Alzheimer disease. Front. Pharmacol. 5:6. doi:10.3389/fphar.2014.00006&lt;/p>
&lt;p>1: Department of Geriatric Medicine, UPRES EA 4638, University Hospital, Angers, France&lt;/p></description></item><item><title>Vitamin D analogs – 25 years of trying to trying to patent vitamin D</title><link>/posts/vitamin-d-analogs-25-years-of-trying-to-trying-to-patent-vitamin-d.html</link><pubDate>Tue, 29 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-analogs-25-years-of-trying-to-trying-to-patent-vitamin-d.html</guid><description>&lt;h2 id="the-future-of-vitamin-d-analogs">The future of vitamin D analogs.&lt;/h2>
&lt;p>Front Physiol. 2014 Apr 3;5:122. eCollection 2014.&lt;/p>
&lt;p>Leyssens C, Verlinden L, Verstuyf A.&lt;/p>
&lt;p>Clinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven Leuven, Belgium.&lt;/p>
&lt;p>The active form of vitamin D3, 1,25-dihydroxyvitamin D3, is a major regulator of bone and calcium homeostasis. In addition, this hormone also inhibits the proliferation and stimulates the differentiation of normal as well as malignant cells. Supraphysiological doses of 1,25-dihydroxyvitamin D3 are required to reduce cancer cell proliferation. &lt;strong>However, these doses will lead in vivo to calcemic side effects such as hypercalcemia and hypercalciuria&lt;/strong> . During the last 25 years, many structural analogs of 1,25-dihydroxyvitamin D3 have been synthesized by the introduction of chemical modifications in the A-ring, central CD-ring region or side chain of 1,25-dihydroxyvitamin D3 in the hope to find molecules with a clear dissociation between the beneficial antiproliferative effects and adverse calcemic side effects. One example of such an analog with a good dissociation ratio is calcipotriol (Daivonex®), which is clinically used to treat the hyperproliferative skin disease psoriasis. Other vitamin D analogs were clinically approved for the treatment of osteoporosis or secondary hyperparathyroidism. No vitamin D analog is currently used in the clinic for the treatment of cancer although several analogs have been shown to be potent drugs in animal models of cancer. Transcriptomics studies as well as in vitro cell biological experiments unraveled basic mechanisms involved in the antineoplastic effects of vitamin D and its analogs. 1,25-dihydroxyvitamin D3 and analogs act in a cell type- and tissue-specific manner. Moreover, a blockade in the transition of the G0/1 toward S phase of the cell cycle, induction of apoptosis, inhibition of migration and invasion of tumor cells together with effects on angiogenesis and inflammation have been implicated in the pleiotropic effects of 1,25-dihydroxyvitamin D3 and its analogs. In this review we will give an overview of the action of vitamin D analogs in tumor cells and look forward how these compounds could be introduced in the clinical practice.&lt;/p></description></item><item><title>Patent application for a skin cream which enhances production of vitamin D – Holick</title><link>/posts/patent-application-for-a-skin-cream-which-enhances-production-of-vitamin-d-holick.html</link><pubDate>Thu, 21 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/patent-application-for-a-skin-cream-which-enhances-production-of-vitamin-d-holick.html</guid><description>&lt;h3 id="compositions-for-providing-vitamin-d-year-round-and-uses-thereofhttpappftusptogovnetacginph-parsersect1pto2sect2hitoffu2fnetahtml2fpto2fsearch-advhtmlr12p1fgl50dpg01s12822vitamind22ttl29osttl22vitamind22rsttl22vitamind22">&lt;a href="http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;amp;Sect2=HITOFF&amp;amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&amp;amp;r=12&amp;amp;p=1&amp;amp;f=G&amp;amp;l=50&amp;amp;d=PG01&amp;amp;S1=%28%22vitamin+d%22.TTL.%29&amp;amp;OS=ttl/%22vitamin+d%22&amp;amp;RS=TTL/%22vitamin+d%22">Compositions for Providing Vitamin D Year Round and Uses Thereof&lt;/a>&lt;/h3>
&lt;p>Methods for enhancing the ability of an individual, exposed to sunlight, to produce vitamin D via the skin. Pharmaceutical compositions comprising provitamin D and at least one of &lt;strong>lumisterol and tachysterol&lt;/strong> and analogs and derivatives thereof are also disclosed.&lt;/p>
&lt;p>&lt;strong>Claim 1&lt;/strong>&lt;/p>
&lt;p>A composition comprising a pharmaceutically acceptable carrier and an effective amount of (a) provitamin D or a derivative or analog thereof; (b) at least one of lumisterol and tachysterol or analogs and/or esters thereof, and (c) a pharmaceutically effective carrier, wherein (a) and (b) are present in amounts effective to provide vitamin D or derivatives or analogs and/or esters thereof to an individual at a particular latitude and/or time of the year.&lt;/p></description></item><item><title>Vitamin D patent update</title><link>/posts/vitamin-d-patent-update.html</link><pubDate>Wed, 06 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patent-update.html</guid><description/></item><item><title>Vitamin D3 analog, 20-hydroxyvitamin D, inhibits cancer cells and is non-toxic</title><link>/posts/vitamin-d3-analog-20-hydroxyvitamin-d-inhibits-cancer-cells-and-is-non-toxic.html</link><pubDate>Wed, 09 May 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d3-analog-20-hydroxyvitamin-d-inhibits-cancer-cells-and-is-non-toxic.html</guid><description/></item><item><title>Vitamin D patents became public - 1946</title><link>/posts/vitamin-d-patents-became-public-1946.html</link><pubDate>Thu, 29 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patents-became-public-1946.html</guid><description>&lt;h1 id="vitamin-rights-given-to-public">VITAMIN RIGHTS GIVEN TO PUBLIC&lt;/h1>
&lt;p>From Spokesman, Jan 15, 1946&lt;/p>
&lt;p>WASHINGTON. Jan. 14. Attorney General Tom C. Clark announced that under a consent Judgment entered today vitamin D patents owned by the Wisconsin Alumni Research foundation have been dedicated to the public.&lt;/p>
&lt;p>The &amp;ldquo;sunshine vitamin.&amp;rdquo; vitamin D prevents and cures rickets.&lt;/p>
&lt;p>Clark said the Judgment, terminating a civil anti-trust suit against the foundation and 17 other firms, was entered In the United States district court at Chicago.&lt;/p></description></item><item><title>Patent to include anti-oxident with vitamin D – 2010</title><link>/posts/patent-to-include-anti-oxident-with-vitamin-d-2010.html</link><pubDate>Mon, 20 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/patent-to-include-anti-oxident-with-vitamin-d-2010.html</guid><description>&lt;p> &lt;/p>
&lt;h2 id="wo2010075537-httpwwwwipointpatentscopesearchendetailjsfjsessionid4fce0140f749968fbbc5e06740d62c30wapp2docidwo2010075537recnum1maxrecofficeprevfiltersortoptionquerystringtabpctdescription20-formulations-comprising-vitamin-d-or-derivatives-thereof">&lt;a href="http://www.wipo.int/patentscope/search/en/detail.jsf;jsessionid=4FCE0140F749968FBBC5E06740D62C30.wapp2?docId=WO2010075537&amp;amp;recNum=1&amp;amp;maxRec=&amp;amp;office=&amp;amp;prevFilter=&amp;amp;sortOption=&amp;amp;queryString=&amp;amp;tab=PCTDescription%20">(WO2010075537) &lt;/a> FORMULATIONS COMPRISING VITAMIN D OR DERIVATIVES THEREOF&lt;/h2>
&lt;h2 id="clipped-from-patent">Clipped from patent&lt;/h2>
&lt;p>“However, cholecalciferol is seen to be very unstable and is &lt;strong>especially unstable in the presence of oxygen&lt;/strong> . It has therefore been difficult to provide formulations of cholecalciferol which are stable. This lack of stability may often be detected as a drop in the level of cholecalciferol in a formulation measured using a cholecalciferol assay.”&lt;/p>
&lt;p>“The present invention provides a stable pharmaceutical delivery system comprising vitamin D or derivatives thereof, preferably cholecalciferol. In a first aspect, the present invention provides a pharmaceutical delivery system comprising: i) an inert core, ii) an inner layer comprising vitamin D or a derivative thereof, preferably cholecalciferol, an emulsifier and an anti-oxidant, and iii) an outer protective layer.”&lt;/p></description></item><item><title>Patent for patients of Chronic Heart Failure includes vitamin D</title><link>/posts/patent-for-patients-of-chronic-heart-failure-includes-vitamin-d.html</link><pubDate>Thu, 16 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/patent-for-patients-of-chronic-heart-failure-includes-vitamin-d.html</guid><description>&lt;p> &lt;/p>
&lt;p>World Patent Office June 9 2011&lt;/p>
&lt;p>Awarded to NEPHROCEUTICALS, LLC &lt;a href="US/US">US/US&lt;/a>;&lt;/p>
&lt;p>&lt;a href="http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2011068920&amp;amp;recNum=34&amp;amp;maxRec=12428&amp;amp;office=&amp;amp;prevFilter=&amp;amp;sortOption=Pub+Date+Desc&amp;amp;queryString=ALL%3A%28%22vitamin+d%22%29&amp;amp;tab=PCT+Biblio%20">WO2011068920)&lt;/a> NUTRITIONAL SUPPLEMENT FOR PATIENTS WITH CHRONIC HEART FAILURE&lt;/p>
&lt;p>Any amount of Vitamin D: 400 – 10,000 IU&lt;/p>
&lt;p>In combination with many other ingredients&lt;/p>
&lt;hr>
&lt;h1 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h1>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-cardiovascular-and-vitamin-d">Overview Cardiovascular and vitamin D&lt;/a>&lt;/p>
&lt;ul>
&lt;li>There are many indications that vitamin D can both PREVENT and TREAT many cardiovascular problems&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/tiki-browse_categories.php?parentId=13&amp;amp;sort_mode=created_desc">All items in Cardiovascular and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/who-said-vitamin-d-could-not-be-patented">Who said vitamin D could not be patented&lt;/a>&lt;/p></description></item><item><title>Patent granted for adding vitamin D to sunblock and skin cream</title><link>/posts/patent-granted-for-adding-vitamin-d-to-sunblock-and-skin-cream.html</link><pubDate>Wed, 16 Feb 2011 00:00:00 +0000</pubDate><guid>/posts/patent-granted-for-adding-vitamin-d-to-sunblock-and-skin-cream.html</guid><description>&lt;h4 id="virtually-the-entire-world-recognizes-that-sunblock-greatly-reduces-the-amount-of-vitamin-d-you-can-get-from-the-sun">Virtually the entire world recognizes that sunblock greatly reduces the amount of vitamin D you can get from the sun.&lt;/h4>
&lt;h4 id="avidas-pharmaceuticals-has-been-granted-an-international-patent-to-add-vitamin-d-to-sunscreen-lotions-and-skin-lotions">AVIDAS PHARMACEUTICALS has been granted an international patent to add vitamin D to sunscreen lotions and skin lotions.&lt;/h4>
&lt;h3 id="wo2011017380-therapeutic-vitamin-d-sun-protecting-formulations-and-methods-for-their-usehttpwwwwipointpctdbenwojspiaus2010044319displaystatus">&lt;a href="http://www.wipo.int/pctdb/en/wo.jsp?IA=US2010044319&amp;amp;DISPLAY=STATUS">(WO/2011/017380) THERAPEUTIC VITAMIN D SUN-PROTECTING FORMULATIONS AND METHODS FOR THEIR USE&lt;/a>&lt;/h3>
&lt;hr>
&lt;p>^One person was unable to use the above hyperlink for some reason, so we have attached&lt;/p>
&lt;p>PDF files of the patent to the bottom of this page^&lt;/p></description></item><item><title>Vitamin D patents and the Wisconsin Alumni Research Foundation</title><link>/posts/vitamin-d-patents-and-the-wisconsin-alumni-research-foundation.html</link><pubDate>Sat, 06 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patents-and-the-wisconsin-alumni-research-foundation.html</guid><description>&lt;h2 id="clipped-from-wikipediahttpenwikipediaorgwikiwisconsin_alumni_research_foundationvitamin_d">Clipped from &lt;a href="http://en.wikipedia.org/wiki/Wisconsin_Alumni_Research_Foundation#Vitamin_D">Wikipedia&lt;/a>&lt;/h2>
&lt;h2 id="vitamin-d">Vitamin D&lt;/h2>
&lt;p>In 1923, Harry Steenbock and James Cockwell discovered exposure to ultraviolet light increased the Vitamin D concentration in food. After discovering that irradiated rat food cured the rats of rickets, Steenbock sought a patent. Steenbock then assigned the patent to the newly established Wisconsin Alumni Research Foundation. WARF then licensed the technology to Quaker Oats for use in their breakfast cereals. In addition, WARF licensed the technology for use as a pharmaceutical, Viosterol. WARF&amp;rsquo;s commercialization of Vitamin D culminated in its enrichment of milk.&lt;/p></description></item><item><title>Patent for combination of vitamin D3 and calcifediol</title><link>/posts/patent-for-combination-of-vitamin-d3-and-calcifediol.html</link><pubDate>Sat, 09 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/patent-for-combination-of-vitamin-d3-and-calcifediol.html</guid><description>&lt;h3 id="wo2009101132-combination-of-vitamin-d-and-25-hydroxyvitamin-d-3">(WO/2009/101132) COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3&lt;/h3>
&lt;h3 id="pdf-with-graphics-is-attached-at-the-bottom-of-this-wiki-page">PDF with graphics is attached at the bottom of this wiki page&lt;/h3>
&lt;h4 id="table-1---copied-from-the-pdf-and-described-in-the-clinical-study-portion">Table 1 - copied from the PDF and described in the clinical study portion&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/gif/patent-table-1.gif" alt="image" style="max-width: 500px;">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/gif/patent-table-1b.gif" alt="image" style="max-width: 500px;">
&lt;h2 id="the-present-invention-relates-to-a-composition-comprising-vitamin-d-cholecalciferol-andor-ergocalciferol-and-25--hydroxy-vitamin-d3-calcifediol-and-use-of-that-composition-to-affect-at-least-concentration-bioavailability-metabolism-or-efficacy-of-vitamin-d">The present invention relates to a composition comprising Vitamin D (cholecalciferol/ and/or ergocalciferol) and 25 -hydroxy Vitamin D3 (calcifediol), and use of that composition to affect at least concentration, bioavailability, metabolism, or efficacy of vitamin D.&lt;/h2>
&lt;p>Pub. No.:	 	WO/2009/101132	 	International Application No.:	 	PCT/EP2009/051636&lt;/p></description></item><item><title>International patent for sublingual liquid analogue forms of vitamin D – 2007</title><link>/posts/international-patent-for-sublingual-liquid-analogue-forms-of-vitamin-d-2007.html</link><pubDate>Thu, 07 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/international-patent-for-sublingual-liquid-analogue-forms-of-vitamin-d-2007.html</guid><description>&lt;h2 id="notes-by-vitamindwiki">Notes by VitaminDWiki:&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>Primarily CALCITRIOL, but other forms are covered by this patent&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Sublingual is absorbed quickly,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Less patient to patient variability,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Good for use when kidney is not working well,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Weekly dosing might be better than daily&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Targets a great number of diseases - especially auto-immune&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>(WO/2007/036802) SUBLINGUAL DOSAGE FORM COMRISING VITAMIN D ANALOGUE, IN PARTICULAR CALCITRIOL&lt;/p>
&lt;p>Pub. No.:	 	WO/2007/036802 	International Application No.: 	PCT/IB2006/002853&lt;/p>
&lt;p>Publication Date:	05.04.2007 	International Filing Date:	07.07.2006&lt;/p></description></item><item><title>Who said vitamin D could not be patented</title><link>/posts/who-said-vitamin-d-could-not-be-patented.html</link><pubDate>Thu, 23 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/who-said-vitamin-d-could-not-be-patented.html</guid><description>&lt;h3 id="a-few-of-the-1000-vitamin-d-entries-for-us-and-international-patents">A few of the 1,000+ vitamin D entries for US and International Patents.&lt;/h3>
&lt;h4 id="most-were-for-vitamin-d-span-stylecolorf00analogsspan-and-vitamin-d-testing">Most were for Vitamin D &lt;span style="color:#F00;">analogs&lt;/span> and vitamin D testing.&lt;/h4>
&lt;h4 id="these-provide-some-insight-as-to-what-vitamin-d-might-help-with-and-shows-vitamin-d-uses-which-cannot-be-mentioned-for-fear-of-having-to-pay-patent-royalties">These provide some insight as to what vitamin D might help with, and shows vitamin D uses which cannot be mentioned for fear of having to pay patent royalties.&lt;/h4>
&lt;h3 id="interesting-to-note-that-a-majority-of-the-patents-are-for-span-stylecolorf00treatingspan-not-span-stylecolor390preventingspan">Interesting to note that a majority of the patents are for &lt;span style="color:#F00;">TREATING&lt;/span>, not &lt;strong>&lt;span style="color:#390;">PREVENTING&lt;/span>&lt;/strong>&lt;/h3>
&lt;h4 id="a-majority-of-these-vitamin-d-patents-are-owned-by--big-pharma-">A majority of these vitamin D patents are owned by &lt;strong>Big Pharma&lt;/strong> .&lt;/h4>
&lt;h4 id="us-patents-for-vitamin-dhttppatftusptogovnetahtmlptosearch-boolhtml">&lt;a href="http://patft.uspto.gov/netahtml/PTO/search-bool.html">US Patents for vitamin D&lt;/a>&lt;/h4>
&lt;p>&lt;a href="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;amp;Sect2=HITOFF&amp;amp;p=1&amp;amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;amp;r=2&amp;amp;f=G&amp;amp;l=50&amp;amp;co1=AND&amp;amp;d=PTXT&amp;amp;s1=%22vitamin+D%22.ABTX.&amp;amp;OS=ABST/%22vitamin+D%22&amp;amp;RS=ABST/%22vitamin+D%22">Method of treating multiple sclerosis&lt;/a> DeLuca March 2022&lt;/p></description></item></channel></rss>